brexit_flag_0

Brexit Health Alliance warns of UK at back of the medicine queue

January 29, 2018
Medical Communications, Sales and Marketing biotech, brexit, drugs, pharma, pharmaceutical

The Brexit Health Alliance (BHA) has cautioned that unless a favourable deal is struck, the UK could end Brexit negotiations …

Sanofi swoops for Ablynx in $4.8bn deal

January 29, 2018
Sales and Marketing Ablynx, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi has moved quickly to tie up a deal with Ablynx for $4.8 billion, when it looked more likely that …

pills_in_hand

NICE urges curbing the use of antibiotics for sore throats

January 26, 2018
Medical Communications Antibiotics, NICE, biotech, drugs, pharma, pharmaceutical

In a study published by the BMJ a few years ago, it was found that antibiotics were prescribed in 60% …

AZ’s triple therapy inhaler hits 8 out of 9 endpoints

January 26, 2018
Medical Communications, Research and Development AstraZeneca, COPD, biotech, drugs, pharma, pharmaceutical

AstraZeneca has made a brief announcement that its triple therapy inhaler manage to successfully hit eight of nine primary endpoints …

iQOS heat-not-burn electronic tobacco product doesn’t reduce health risk, FDA says

January 26, 2018
Medical Communications, Sales and Marketing FDA, Philip Morris, iQOS, pharma, smoking, tobacco

An advisory panel of the FDA has judged that US tobacco firm Philip Morris International (PMI) has not been able …

Biogen announces acquisition along with financials, but it’s tiny

January 26, 2018
Medical Communications, Sales and Marketing Biogen, Karyopharm, biotech, drugs, pharma, pharmaceutical

Biogen is one those companies, like Sanofi until its recent Bioverativ acquisition, that has real pressure to make a big …

aging_-_hand

Senescent cell findings provides Parkinson’s treatment clue

January 25, 2018
Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical

Senescent cells are the dormant state that cells shift to in response to certain stressors, it is thought that they …

spark_v2

Spark hands over Luxturna rights outside US to Novartis for $170m

January 25, 2018
Sales and Marketing Luxturna, Novartis, Spark Therapeutics, pharma

Novartis has confirmed a deal worth a potential $170 million with Spark Therapeutics to develop and commercialise its gene therapy …

old_man_bar

Amyloid pathway doubts after latest Alzheimer’s failure

January 25, 2018
Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical

There has been another drug failure in a large Phase 3 that once again crushes a hope for a possible …

alex_azar_wwsg_photo_cropped

Trump nominee and ex-Lilly exec confirmed as US Health Secretary by Senate

January 25, 2018
Manufacturing and Production, Medical Communications, Sales and Marketing Alex Azar, Eli Lilly, President trump, Trump, US, pharma

Alex Azar, President’s Trump’s controversial pick for Health and Human Services Secretary (HHS), has been confirmed in the role after …

gw_pharma

GW Pharma boasts new positive data, readying for approval

January 25, 2018
Research and Development GW Pharma, biotech, drugs, pharma, pharmaceutical

The latest data from GW Pharma is about as conclusively positive as you can usually hope to get with a …

influenza_dan_higgins_douglas_jordan_uscdcp

New vaccine provides universal protection against influenza A, study finds

January 24, 2018
Research and Development Georgia State University, Vaccine, flu, influenza, pharma

Research led by Georgia State University has enabled the development of a universal vaccine for influenza A viruses, proven to …

shutterstock_92671375

US court upholds ruling that J&J’s Remicade patent is invalid

January 24, 2018
Research and Development, Sales and Marketing J&J, JJ, Johnson & Johnson, Remicade, biosimilars, infliximab, patent, pharma

The US Court of Appeals for the Federal Circuit has judged that Johnson & Johnson’s patent for its best-selling arthritis …

shutterstock_138095450

New York City launches $500 million lawsuit against big pharma over opioid crisis

January 24, 2018
Research and Development, Sales and Marketing New York City, opioid crisis, opioids, pharma

The administration of New York City Mayor Bill de Blasio has announced its intention to bring legal action against the …

lilly_entrance_web

Eli Lilly’s Taltz get EU approval in psoriatic arthritis subgroup

January 24, 2018
Research and Development, Sales and Marketing EU, Eli Lilly, Europe, European Commission, Taltz, pharma, psoriatic arthritis

Eli Lilly has revealed that its IgG4 monoclonal antibody Taltz (ixekizumab) has been awarded marketing approval from the European Commission …

shutterstock_157775444

NICE recommends for online and mobile depression programme for trial on NHS

January 24, 2018
Research and Development Deprexis, NHS, NICE, app, depression, pharma

NICE has said that a new online and mobile app should be trialled on the NHS in the treatment of …

jj_sign_on_wall

J&J withdraws controversial vaginal mesh from Australian market

January 23, 2018
Manufacturing and Production, Sales and Marketing J&J, JJ, Johnson & Johnson, lawsuit, pharma, vaginal mesh

Johnson & Johnson has withdrawn its controversial vaginal mesh product from the Australian market after missing a deadline requiring all …

shutterstock_274590824

GSK wins case against Reckitt Benckiser over misleading ad campaign

January 23, 2018
Manufacturing and Production, Sales and Marketing GSK, GlaxoSmithKline, Nurofen, Panadol, Reckitt Benckiser, ibuprofen, paracetamol, pharma

GlaxoSmithKline is celebrating as it emerges that the UK pharma giant triumphed in its legal battle against Reckitt Benckiser after …

teva_copy

More woes for Teva as two late-stage asthma studies bomb

January 23, 2018
Manufacturing and Production, Research and Development Teva, asthma, pharma

In yet more bad news for Teva, it has emerged that two of the firm’s late-stage studies in asthma have …

The Gateway to Local Adoption Series

Latest content